Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

How Are Telehealth Laws Intersecting With Laws Addressing the Opioid Overdose Epidemic?

Pepin D, Hulkower R, McCord RF.

J Public Health Manag Pract. 2019 Jul 24. doi: 10.1097/PHH.0000000000001036. [Epub ahead of print]

PMID:
31348152
2.

Civil Rights Law and the Determinants of Health: How Some States Have Utilized Civil Rights Laws to Increase Protections Against Discrimination.

Pepin D, Weber SB.

J Law Med Ethics. 2019 Jun;47(2_suppl):76-79. doi: 10.1177/1073110519857323.

PMID:
31298134
3.

Broadband Access as a Public Health Issue: The Role of Law in Expanding Broadband Access and Connecting Underserved Communities for Better Health Outcomes.

Bauerly BC, McCord RF, Hulkower R, Pepin D.

J Law Med Ethics. 2019 Jun;47(2_suppl):39-42. doi: 10.1177/1073110519857314.

PMID:
31298126
4.

Single-cell sequencing of neonatal uterus reveals an Misr2+ endometrial progenitor indispensable for fertility.

Saatcioglu HD, Kano M, Horn H, Zhang L, Samore W, Nagykery N, Meinsohn MC, Hyun M, Suliman R, Poulo J, Hsu J, Sacha C, Wang D, Gao G, Lage K, Oliva E, Morris Sabatini ME, Donahoe PK, Pépin D.

Elife. 2019 Jun 24;8. pii: e46349. doi: 10.7554/eLife.46349.

5.

Association of State Laws With Influenza Vaccination of Hospital Personnel.

Lindley MC, Mu Y, Hoss A, Pepin D, Kalayil EJ, van Santen KL, Edwards JR, Pollock DA.

Am J Prev Med. 2019 Jun;56(6):e177-e183. doi: 10.1016/j.amepre.2019.01.011. Epub 2019 Apr 17.

PMID:
31003802
6.

Pea polyphenolics and hydrolysis processing alter microbial community structure and early pathogen colonization in mice.

Forgie AJ, Gao Y, Ju T, Pepin DM, Yang K, Gänzle MG, Ozga JA, Chan CB, Willing BP.

J Nutr Biochem. 2019 May;67:101-110. doi: 10.1016/j.jnutbio.2019.01.012. Epub 2019 Feb 8.

PMID:
30877891
7.

Evaluation of State-Mandated Reporting of Neonatal Abstinence Syndrome - Six States, 2013-2017.

Jilani SM, Frey MT, Pepin D, Jewell T, Jordan M, Miller AM, Robinson M, St Mars T, Bryan M, Ko JY, Ailes EC, McCord RF, Gilchrist J, Foster S, Lind JN, Culp L, Penn MS, Reefhuis J.

MMWR Morb Mortal Wkly Rep. 2019 Jan 11;68(1):6-10. doi: 10.15585/mmwr.mm6801a2.

8.

Müllerian inhibiting substance/anti-Müllerian hormone as a fertility preservation agent.

Pépin D, Sabatini ME, Donahoe PK.

Curr Opin Endocrinol Diabetes Obes. 2018 Dec;25(6):399-405. doi: 10.1097/MED.0000000000000442. Review.

PMID:
30320617
9.

Towards international standardization of immunoassays for Müllerian inhibiting substance/anti-Müllerian hormone.

Ferguson JM, Pépin D, Duru C, Matejtschuk P, Donahoe PK, Burns CJ.

Reprod Biomed Online. 2018 Nov;37(5):631-640. doi: 10.1016/j.rbmo.2018.08.012. Epub 2018 Sep 5.

10.

Müllerian-Inhibiting Substance/Anti-Müllerian Hormone as a Predictor of Preterm Birth in Polycystic Ovary Syndrome.

Hsu JY, James KE, Bormann CL, Donahoe PK, Pépin D, Sabatini ME.

J Clin Endocrinol Metab. 2018 Nov 1;103(11):4187-4196. doi: 10.1210/jc.2018-01320.

PMID:
30239805
11.

Quantification of Müllerian Inhibiting Substance/Anti-Müllerian Hormone polypeptide by isotope dilution mass spectrometry.

Whiting G, Ferguson J, Fang M, Pepin D, Donahoe P, Matejtschuk P, Burns C, Wheeler JX.

Anal Biochem. 2018 Nov 1;560:50-55. doi: 10.1016/j.ab.2018.05.006. Epub 2018 May 6.

PMID:
29742446
12.

Publisher Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer.

Qi R, Wang Y, Bruno PM, Xiao H, Yu Y, Li T, Lauffer S, Wei W, Chen Q, Kang X, Song H, Yang X, Huang X, Detappe A, Matulonis U, Pepin D, Hemann MT, Birrer MJ, Ghoroghchian PP.

Nat Commun. 2018 Feb 7;9(1):628. doi: 10.1038/s41467-018-02963-0.

13.

Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer.

Qi R, Wang Y, Bruno PM, Xiao H, Yu Y, Li T, Lauffer S, Wei W, Chen Q, Kang X, Song H, Yang X, Huang X, Detappe A, Matulonis U, Pepin D, Hemann MT, Birrer MJ, Ghoroghchian PP.

Nat Commun. 2017 Dec 18;8(1):2166. doi: 10.1038/s41467-017-02390-7. Erratum in: Nat Commun. 2018 Feb 7;9(1):628.

14.

Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency.

Collet TH, Dubern B, Mokrosinski J, Connors H, Keogh JM, Mendes de Oliveira E, Henning E, Poitou-Bernert C, Oppert JM, Tounian P, Marchelli F, Alili R, Le Beyec J, Pépin D, Lacorte JM, Gottesdiener A, Bounds R, Sharma S, Folster C, Henderson B, O'Rahilly S, Stoner E, Gottesdiener K, Panaro BL, Cone RD, Clément K, Farooqi IS, Van der Ploeg LHT.

Mol Metab. 2017 Oct;6(10):1321-1329. doi: 10.1016/j.molmet.2017.06.015. Epub 2017 Jul 8.

15.

Transitioning From Paper to Digital: State Statutory and Regulatory Frameworks for Health Information Technology.

Schmit C, Sunshine G, Pepin D, Ramanathan T, Menon A, Penn M.

Public Health Rep. 2017 Sep/Oct;132(5):585-592. doi: 10.1177/0033354917722994. Epub 2017 Aug 16.

16.

Collaborating for Health: Health in All Policies and the Law.

Pepin D, Winig BD, Carr D, Jacobson PD.

J Law Med Ethics. 2017 Mar;45(1_suppl):60-64. doi: 10.1177/1073110517703327.

17.

Legal Authority for Mosquito Control and Pesticide Use in the United States.

Pepin D, Penn M.

Public Health Rep. 2017 May/Jun;132(3):389-391. doi: 10.1177/0033354917704628. Epub 2017 Apr 10. No abstract available.

18.

Targeting biofilms of multidrug-resistant bacteria with silver oxynitrate.

Kalan LR, Pepin DM, Ul-Haq I, Miller SB, Hay ME, Precht RJ.

Int J Antimicrob Agents. 2017 Jun;49(6):719-726. doi: 10.1016/j.ijantimicag.2017.01.019. Epub 2017 Apr 5.

19.

Müllerian inhibiting substance inhibits an ovarian cancer cell line via β-catenin interacting protein deregulation of the Wnt signal pathway.

Park SH, Chung YJ, Song JY, Kim SI, Pépin D, MacLaughlin DT, Donahoe PK, Kim JH.

Int J Oncol. 2017 Mar;50(3):1022-1028. doi: 10.3892/ijo.2017.3874. Epub 2017 Feb 13.

PMID:
28197641
20.

AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy.

Kano M, Sosulski AE, Zhang L, Saatcioglu HD, Wang D, Nagykery N, Sabatini ME, Gao G, Donahoe PK, Pépin D.

Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):E1688-E1697. doi: 10.1073/pnas.1620729114. Epub 2017 Jan 30.

21.

Anti-Müllerian Hormone Signaling Regulates Epithelial Plasticity and Chemoresistance in Lung Cancer.

Beck TN, Korobeynikov VA, Kudinov AE, Georgopoulos R, Solanki NR, Andrews-Hoke M, Kistner TM, Pépin D, Donahoe PK, Nicolas E, Einarson MB, Zhou Y, Boumber Y, Proia DA, Serebriiskii IG, Golemis EA.

Cell Rep. 2016 Jul 19;16(3):657-71. doi: 10.1016/j.celrep.2016.06.043. Epub 2016 Jul 7.

22.

Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery.

Denis JA, Patroni A, Guillerm E, Pépin D, Benali-Furet N, Wechsler J, Manceau G, Bernard M, Coulet F, Larsen AK, Karoui M, Lacorte JM.

Mol Oncol. 2016 Oct;10(8):1221-31. doi: 10.1016/j.molonc.2016.05.009. Epub 2016 Jun 7.

23.

CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.

Sosulski A, Horn H, Zhang L, Coletti C, Vathipadiekal V, Castro CM, Birrer MJ, Nagano O, Saya H, Lage K, Donahoe PK, Pépin D.

PLoS One. 2016 Jun 2;11(6):e0156595. doi: 10.1371/journal.pone.0156595. eCollection 2016.

24.

Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer.

Basal E, Ayeni T, Zhang Q, Langstraat C, Donahoe PK, Pepin D, Yin X, Leof E, Cliby W.

Curr Mol Med. 2016;16(3):222-31.

25.

State and Territorial Ebola Screening, Monitoring, and Movement Policy Statements - United States, August 31, 2015.

Sunshine G, Pepin D, Cetron M, Penn M.

MMWR Morb Mortal Wkly Rep. 2015 Oct 16;64(40):1145-6. doi: 10.15585/mmwr.mm6440a4. No abstract available.

26.

AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer.

Pépin D, Sosulski A, Zhang L, Wang D, Vathipadiekal V, Hendren K, Coletti CM, Yu A, Castro CM, Birrer MJ, Gao G, Donahoe PK.

Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):E4418-27. doi: 10.1073/pnas.1510604112. Epub 2015 Jul 27.

27.

Seven novel deleterious LEPR mutations found in early-onset obesity: a ΔExon6-8 shared by subjects from Reunion Island, France, suggests a founder effect.

Huvenne H, Le Beyec J, Pépin D, Alili R, Kherchiche PP, Jeannic E, Frelut ML, Lacorte JM, Nicolino M, Viard A, Laville M, Ledoux S, Tounian P, Poitou C, Dubern B, Clément K.

J Clin Endocrinol Metab. 2015 May;100(5):E757-66. doi: 10.1210/jc.2015-1036. Epub 2015 Mar 9.

PMID:
25751111
28.

Conversion of the LIN-1 ETS protein of Caenorhabditis elegans from a SUMOylated transcriptional repressor to a phosphorylated transcriptional activator.

Leight ER, Murphy JT, Fantz DA, Pepin D, Schneider DL, Ratliff TM, Mohammad DH, Herman MA, Kornfeld K.

Genetics. 2015 Mar;199(3):761-75. doi: 10.1534/genetics.114.172668. Epub 2015 Jan 7.

29.

Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase I inhibitor or radiation.

Sabbatino F, Fusciello C, Somma D, Pacelli R, Poudel R, Pepin D, Leonardi A, Carlomagno C, Della Vittoria Scarpati G, Ferrone S, Pepe S.

Cytometry A. 2014 Nov;85(11):953-61. doi: 10.1002/cyto.a.22563. Epub 2014 Sep 2.

30.

Plasma proteins predict conversion to dementia from prodromal disease.

Hye A, Riddoch-Contreras J, Baird AL, Ashton NJ, Bazenet C, Leung R, Westman E, Simmons A, Dobson R, Sattlecker M, Lupton M, Lunnon K, Keohane A, Ward M, Pike I, Zucht HD, Pepin D, Zheng W, Tunnicliffe A, Richardson J, Gauthier S, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S.

Alzheimers Dement. 2014 Nov;10(6):799-807.e2. doi: 10.1016/j.jalz.2014.05.1749. Epub 2014 Jul 8.

31.

PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation.

Sabbatino F, Wang Y, Wang X, Flaherty KT, Yu L, Pepin D, Scognamiglio G, Pepe S, Kirkwood JM, Cooper ZA, Frederick DT, Wargo JA, Ferrone S, Ferrone CR.

Oncotarget. 2014 Apr 15;5(7):1926-41.

32.

An albumin leader sequence coupled with a cleavage site modification enhances the yield of recombinant C-terminal Mullerian Inhibiting Substance.

Pépin D, Hoang M, Nicolaou F, Hendren K, Benedict LA, Al-Moujahed A, Sosulski A, Marmalidou A, Vavvas D, Donahoe PK.

Technology. 2013 Sep;1(1):63-71.

33.

The imitation switch ATPase Snf2l is required for superovulation and regulates Fgl2 in differentiating mouse granulosa cells.

Pépin D, Paradis F, Perez-Iratxeta C, Picketts DJ, Vanderhyden BC.

Biol Reprod. 2013 Jun 6;88(6):142. doi: 10.1095/biolreprod.112.105742. Print 2013 Jun.

PMID:
23616592
34.

Homozygous leptin receptor mutation due to uniparental disomy of chromosome 1: response to bariatric surgery.

Le Beyec J, Cugnet-Anceau C, Pépin D, Alili R, Cotillard A, Lacorte JM, Basdevant A, Laville M, Clément K.

J Clin Endocrinol Metab. 2013 Feb;98(2):E397-402. doi: 10.1210/jc.2012-2779. Epub 2012 Dec 28.

PMID:
23275530
35.

Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance.

Meirelles K, Benedict LA, Dombkowski D, Pepin D, Preffer FI, Teixeira J, Tanwar PS, Young RH, MacLaughlin DT, Donahoe PK, Wei X.

Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2358-63. doi: 10.1073/pnas.1120733109. Epub 2012 Jan 27.

36.

Kallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft model.

Pépin D, Shao ZQ, Huppé G, Wakefield A, Chu CW, Sharif Z, Vanderhyden BC.

PLoS One. 2011;6(11):e26075. doi: 10.1371/journal.pone.0026075. Epub 2011 Nov 15.

37.

Spatial organization and spatial distribution of activities within home ranges in a Springbok (Antidorcas marsupialis) captive population.

Mechkour F, Maublanc ML, Bideau E, Gerard JF, Pépin D.

Zoo Biol. 2008 Jan;27(1):19-35. doi: 10.1002/zoo.20152.

PMID:
19360601
38.

ISWI chromatin remodeling in ovarian somatic and germ cells: revenge of the NURFs.

Pépin D, Vanderhyden BC, Picketts DJ, Murphy BD.

Trends Endocrinol Metab. 2007 Jul;18(5):215-24. Epub 2007 Jun 1. Review.

PMID:
17544291
39.

Homogenization of regional river dynamics by dams and global biodiversity implications.

Poff NL, Olden JD, Merritt DM, Pepin DM.

Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5732-7. Epub 2007 Mar 12.

40.

The imitation switch protein SNF2L regulates steroidogenic acute regulatory protein expression during terminal differentiation of ovarian granulosa cells.

Lazzaro MA, Pépin D, Pescador N, Murphy BD, Vanderhyden BC, Picketts DJ.

Mol Endocrinol. 2006 Oct;20(10):2406-17. Epub 2006 Jun 1.

PMID:
16740656
41.

Performance of differential GPS collars in temperate mountain forest.

Janeau G, Adrados C, Joachim J, Gendner JP, Pépin D.

C R Biol. 2004 Dec;327(12):1143-9.

PMID:
15656356
42.

Mutation accumulation, performance, fitness.

Huey RB, Gilchrist GW, Ward K, Maves L, Pepin D, Houle D.

Integr Comp Biol. 2003 Jul;43(3):387-95. doi: 10.1093/icb/43.3.387.

PMID:
21680447
43.

Effect of short-chain fructooligosaccharides on intestinal calcium absorption and calcium status in postmenopausal women: a stable-isotope study.

Tahiri M, Tressol JC, Arnaud J, Bornet FR, Bouteloup-Demange C, Feillet-Coudray C, Brandolini M, Ducros V, Pépin D, Brouns F, Roussel AM, Rayssiguier Y, Coudray C.

Am J Clin Nutr. 2003 Feb;77(2):449-57.

PMID:
12540407
44.

Conversion of dehydroepiandrosterone sulfate at physiological plasma concentration into estrogens in MCF-7 cells.

Le Bail JC, Lotfi H, Charles L, Pépin D, Habrioux G.

Steroids. 2002 Dec;67(13-14):1057-64.

PMID:
12441191
45.

Drinking water and cardiovascular disease.

Sauvant MP, Pepin D.

Food Chem Toxicol. 2002 Oct;40(10):1311-25. Review.

PMID:
12387296
46.

Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status.

Violette S, Poulain L, Dussaulx E, Pepin D, Faussat AM, Chambaz J, Lacorte JM, Staedel C, Lesuffleur T.

Int J Cancer. 2002 Apr 1;98(4):498-504.

47.

[The community pharmacist and the problem of excessive drinkers].

Pouyet-Poulet E, Sauvant MP, Pépin D, Planche R.

Sante Publique. 2001 Sep;13(3):237-48. French.

PMID:
11826843
48.

Exchangeable magnesium pool masses in healthy women: effects of magnesium supplementation.

Feillet-Coudray C, Coudray C, Tressol JC, Pépin D, Mazur A, Abrams SA, Rayssiguier Y.

Am J Clin Nutr. 2002 Jan;75(1):72-8.

PMID:
11756062
49.

Five-week intake of short-chain fructo-oligosaccharides increases intestinal absorption and status of magnesium in postmenopausal women.

Tahiri M, Tressol JC, Arnaud J, Bornet F, Bouteloup-Demange C, Feillet-Coudray C, Ducros V, Pépin D, Brouns F, Rayssiguier AM, Coudray C.

J Bone Miner Res. 2001 Nov;16(11):2152-60.

Supplemental Content

Support Center